posted on 2025-11-12, 01:50authored byCuizhe Wang, Yanting Hou, Meixiu Zhang, Jingzhou Wang, Xiaolong Chu, Maodi Liang, Chaoyue Sun, Jianxin Xie, Jun Zhang, Cong-Yi Wang
<p dir="ltr">MicroRNAs are key regulators of metabolic homeostasis, yet their role in obesity-associated dysfunction remains incompletely understood. Here, we identify miR-432 as a driver of systemic metabolic dysregulation. Serum microRNAs profiling revealed a positive correlation between miR-432 expression and obesity/type 2 diabetes mellitus. Functionally, adipose-specific miR-432 exacerbated HFD-induced obesity and insulin resistance. Similarly, hepatic-specific miR-432 aggravated hepatic steatosis and systemic glucose dysregulation, while skeletal muscle-specific miR-432 disrupted glucose homeostasis without affecting body composition. Mechanistically, miR-432 disrupted insulin sensitivity by inhibiting the PIK3R3/AKT pathway and perturbed lipid homeostasis by suppressing the PIK3R3/PPARα axis. Notably, obesity-induced miR-432 upregulation was predominantly localized in adipocytes and driven by the CDK5-PPARγ axis. Furthermore, adipocyte-derived exosomal miR-432 was identified as a mediator of systemic metabolic dysfunction, facilitating inter-tissue crosstalk in obesity. Collectively, our data demonstrate that miR-432 exacerbates obesity-induced dysregulation of glucose and lipid metabolism.</p>
Funding
The research received funding from the National Natural Science Foundation of China (82260162, 82160156, 81960152), the "Tianshan Talents" Training Program of the Autonomous Region (2023TSYCQNTJ0032, 2023TSYCCX0116), and the Scientific and Technological Research Project of Xinjiang Production and Construction Corps (2022ZD001, 2022AB022, 2021AB028, 2023ZD037, 2023AB057).